NEW YORK, Aug. 07, 2017 -- Dr. Anthony Stein, Hematologist/Oncologist, Director of the Leukemia Program, Co-Director of the Gehr Family Center for Leukemia Research, and Clinical Professor of Hematology & Hematopoietic Transplantation at City of Hope in Duarte, is being recognized as one of “America’s Best Doctors”. He will be sharing his knowledge and expertise in Hematology, Oncology, and Medical Oncology.
Dr. Stein has been active in the healthcare industry for the past 38 years. He obtained his M.D. from the University of Cape Town Medical School in Cape Town, South Africa, in 1978 and is board certified in Internal Medicine, Oncology, and Hematology. He completed his internship at the Groote Schuur Hospital (1979), residency at Montefiore Hospital (1985), and fellowship at City of Hope (1988). His interest in Adult Leukemia, as well as his background of clinical training in the field of Oncology during the ‘80s, led him to his current work.
Dr. Stein’s day-to-day responsibilities at City of Hope include leadership and oversight within the hospital’s Leukemia Department, research, and patient care. City of Hope is a leading research and treatment center for cancer, diabetes, and other life-threatening diseases. Designated as a comprehensive cancer center, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the nation.
Dr. Stein attributes his success throughout the course of his career to his more than 30 years of experience in Clinical Research, as well as his various medical publications. He is honored to be Co-Chair of the Leukemia Program at City of Hope, to have his certification in Internal Medicine and Hematology, and to have written a number of peer-reviewed publications regarding his research on Leukemia drugs and treatments. Of all his accomplishments, Dr. Stein is most proud of the work he does to improve the outcome of treatment for his patients. His long-term professional goals include continued growth and further research that will lead to the discovery of new treatments for patients diagnosed with Adult Leukemia.
Dr. Stein is a member of ASH, ASCO, and ASBMT. Charitable organizations he works with include the Leukemia Society.
In his free time, Dr. Stein enjoys playing soccer.
About the American Health Council:
The American Health Council is the nation’s only organization with a constituency representative of all sectors of the healthcare industry. From the coasts to the heartland, the American Health Council has drawn Affiliates from major metropolitan hubs and small communities. These Affiliates span generations and have reached different stages of their careers — from recent graduates to retirees. More information about the American Health Council and its mission can be found at: http://americanhealthcouncil.org
Additionally, the American Health Council strives to provide recognition and support for those individuals and institutions making the difference in patients’ lives day in and day out. Throughout 2017, the AHC is honoring “America’s Best Doctors and Nurses,” as well as the nation’s best medical universities and hospitals. The American Health Council’s “Best in Medicine” and “Best in Nursing” awards programs honor the individuals and institutions that have contributed significantly to medicine and nursing, as well as the training and education of physicians and nurses. The most current selections for these honors may be viewed here: http://bestinmedicine.org and http://bestinnursing.org.
For more information, please contact: Elizabeth Moore American Health Council Hauppauge, NY United States Phone: 1-212-390-0214 Email: [email protected]


Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
OpenAI Explores Massive Funding Round at $750 Billion Valuation
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 



